AI-generated summary
In this study of ovariectomized rats used as a model of menopause, the authors report that photobiomodulation at 660 nm was associated with lower blood pressure and improved endothelium-dependent vasodilation compared with untreated ovariectomized rats. They also report higher serum nitric oxide levels in the treated group. Findings come from an animal study with a small sample, so they may not apply to humans.
- Participants
- 26
- Who or what was studied
- Female Wistar rats (70 days old) randomly assigned to sham, ovariectomized, or ovariectomized plus photobiomodulation groups
- Wavelengths
- 660 nm
- Limits stated in the abstract
- This is an animal study with a small sample size, and the abstract does not establish human relevance.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 100mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Sham, Low-level laser therapy, Angiogenesis, Inflammation, Nitric oxide, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.